Yüklüyor......
Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
BACKGROUND: Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated...
Kaydedildi:
| Yayımlandı: | Int J Neuropsychopharmacol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5737519/ https://ncbi.nlm.nih.gov/pubmed/29016822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx060 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|